Format

Send to

Choose Destination
See comment in PubMed Commons below
Exp Mol Pathol. 2009 Jun;86(3):165-73. doi: 10.1016/j.yexmp.2009.01.005. Epub 2009 Jan 20.

Prospects for clinical cancer metabolomics using stable isotope tracers.

Author information

1
JG Brown Cancer Center, Louisville KY 40202, USA. anlane01@louisville.edu

Abstract

Metabolomics provides a readout of the state of metabolism in cells or tissue and their responses to external perturbations. For this reason, the approach has great potential in clinical diagnostics. For more than two decades, we have been using stable isotope tracer approaches to probe cellular metabolism in greater detail. The ability to enrich common compounds with rare isotopes such as carbon ((13)C) and nitrogen ((15)N) is the only practical means by which metabolic pathways can be traced, which entails following the fate of individual atoms from the source molecule to products via metabolic transformation. Changes in regulation of pathways are therefore captured by this approach, which leads to deeper understanding of the fundamental biochemistry of cells. Using lessons learned from pathways tracing in cells and organs, we have been applying this methodology to human cancer patients in a clinical setting. Here we review the methodologies and approaches to stable isotope tracing in cells, animal models and in humans subjects.

PMID:
19454273
PMCID:
PMC2685876
DOI:
10.1016/j.yexmp.2009.01.005
[Indexed for MEDLINE]
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science Icon for PubMed Central
    Loading ...
    Support Center